Takeda Emerging Market Strategy Varies From Country To Country

Takeda’s expansion into emerging markets using its Nycomed acquisition have positioned it well in Russia and Brazil and given Japan’s largest drug maker a small but solid base in China, but its head of international operations says he’s in no rush to expand into India, given the fluid and complex nature of that market.